Literature DB >> 30923129

A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism.

My S Mansueto1, Abigail Reens1, Larissa Rakhilina1, An Chi2, Bo-Sheng Pan1, J Richard Miller3.   

Abstract

Spleen tyrosine kinase (SYK) is a signaling node in many immune pathways and comprises two tandem Src homology (SH) 2 domains, an SH2-kinase linker, and a C-terminal tyrosine kinase domain. Two prevalent models of SYK activation exist. The "OR-gate" model contends that SYK can be fully activated by phosphorylation or binding of its SH2 domains to a dual-phosphorylated immune-receptor tyrosine-based activation motif (ppITAM). An alternative model proposes that SYK activation requires ppITAM binding and phosphorylation of the SH2-kinase linker by a SRC family kinase such as LYN proto-oncogene, SRC family tyrosine kinase (LYN). To evaluate these two models, we generated directly comparable unphosphorylated (upSYK) and phosphorylated (pSYK) proteins with or without an N-terminal glutathione S-transferase (GST) tag, resulting in monomeric or obligatory dimeric SYK, respectively. We assessed the ability of a ppITAM peptide and LYN to activate these SYK proteins. The ppITAM peptide strongly activated GST-SYK but was less effective in activating upSYK untagged with GST. LYN alone activated untagged upSYK to a greater extent than did ppITAM, and inclusion of both proteins rapidly and fully activated upSYK. Using immunoblot and phosphoproteomic approaches, we correlated the kinetics and order of site-specific SYK phosphorylation. Our results are consistent with the alternative model, indicating that ppITAM binding primes SYK for rapid LYN-mediated phosphorylation of Tyr-352 and then Tyr-348 of the SH2-kinase linker, which facilitates activation loop phosphorylation and full SYK activation. This gradual activation mechanism may also explain how SYK maintains ligand-independent tonic signaling, important for B-cell development and survival.
© 2019 Mansueto et al.

Entities:  

Keywords:  ITAM (immune-receptor tyrosine activation motif); autophosphorylation; cell signaling; conformational change; enzyme activation; enzyme kinetics; immunity; non-receptor tyrosine kinase (nRTK); phosphorylation; spleen tyrosine kinase (SYK); tonic signalling

Mesh:

Substances:

Year:  2019        PMID: 30923129      PMCID: PMC6514621          DOI: 10.1074/jbc.RA119.008045

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates.

Authors:  Melissa D Shults; Kevin A Janes; Douglas A Lauffenburger; Barbara Imperiali
Journal:  Nat Methods       Date:  2005-03-23       Impact factor: 28.547

2.  Steady state kinetics of spleen tyrosine kinase investigated by a real time fluorescence assay.

Authors:  Eva Papp; Joyce K Y Tse; Hoangdung Ho; Sandra Wang; David Shaw; Simon Lee; Jim Barnett; David C Swinney; J Michael Bradshaw
Journal:  Biochemistry       Date:  2007-12-01       Impact factor: 3.162

Review 3.  ITAM-mediated tonic signalling through pre-BCR and BCR complexes.

Authors:  John G Monroe
Journal:  Nat Rev Immunol       Date:  2006-04       Impact factor: 53.106

4.  Crystallization of glutathione S-transferase from human placenta.

Authors:  M W Parker; M Lo Bello; G Federici
Journal:  J Mol Biol       Date:  1990-05-20       Impact factor: 5.469

Review 5.  Lyn tyrosine kinase: accentuating the positive and the negative.

Authors:  Yuekang Xu; Kenneth W Harder; Nicholas D Huntington; Margaret L Hibbs; David M Tarlinton
Journal:  Immunity       Date:  2005-01       Impact factor: 31.745

6.  Phosphorylated immunoreceptor tyrosine-based activation motifs and integrin cytoplasmic domains activate spleen tyrosine kinase via distinct mechanisms.

Authors:  Lina Antenucci; Vesa P Hytönen; Jari Ylänne
Journal:  J Biol Chem       Date:  2018-02-12       Impact factor: 5.157

7.  A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes.

Authors:  Hoon-Suk Cha; David L Boyle; Tomoyuki Inoue; Reineke Schoot; Paul P Tak; Polly Pine; Gary S Firestein
Journal:  J Pharmacol Exp Ther       Date:  2006-02-01       Impact factor: 4.030

8.  Quantitative analysis of complex peptide mixtures using FTMS and differential mass spectrometry.

Authors:  Fanyu Meng; Matthew C Wiener; Jeffrey R Sachs; Chrissina Burns; Priyanka Verma; Cloud P Paweletz; Matthew T Mazur; Ekaterina G Deyanova; Nathan A Yates; Ronald C Hendrickson
Journal:  J Am Soc Mass Spectrom       Date:  2006-10-25       Impact factor: 3.109

9.  Syk- and Lyn-dependent phosphorylation of Syk on multiple tyrosines following B cell activation includes a site that negatively regulates signaling.

Authors:  L M Keshvara; C C Isaacson; T M Yankee; R Sarac; M L Harrison; R L Geahlen
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

Review 10.  Getting Syk: spleen tyrosine kinase as a therapeutic target.

Authors:  Robert L Geahlen
Journal:  Trends Pharmacol Sci       Date:  2014-06-26       Impact factor: 14.819

View more
  5 in total

1.  Molecular dynamics simulations of the conformational plasticity in the active pocket of salt-inducible kinase 2 (SIK2) multi-state binding with bosutinib.

Authors:  Mingsong Shi; Lun Wang; Kongjun Liu; Yong Chen; Mengshi Hu; Linyu Yang; Jun He; Lijuan Chen; Dingguo Xu
Journal:  Comput Struct Biotechnol J       Date:  2022-05-23       Impact factor: 6.155

2.  Amurensin H, a Derivative From Resveratrol, Ameliorates Lipopolysaccharide/Cigarette Smoke-Induced Airway Inflammation by Blocking the Syk/NF-κB Pathway.

Authors:  Yannan Fan; Ziqian Zhang; Chunsuo Yao; Jinye Bai; Hui Yang; Pei Ma; Yiyao Fan; Shuyi Li; Jiqiao Yuan; Mingbao Lin; Qi Hou
Journal:  Front Pharmacol       Date:  2019-10-04       Impact factor: 5.810

3.  The Serine/Threonine Protein Phosphatase 2A (PP2A) Regulates Syk Activity in Human Platelets.

Authors:  Stephanie Makhoul; Elena Kumm; Pengyu Zhang; Ulrich Walter; Kerstin Jurk
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

4.  A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas.

Authors:  Manit Munshi; Xia Liu; Amanda Kofides; Nickolas Tsakmaklis; Maria Luisa Guerrera; Zachary R Hunter; M Lia Palomba; Kimon V Argyropoulos; Christopher J Patterson; Alexa G Canning; Kirsten Meid; Joshua Gustine; Andrew R Branagan; Catherine A Flynn; Shayna Sarosiek; Jorge J Castillo; Jinhua Wang; Sara J Buhrlage; Nathanael S Gray; Nikhil C Munshi; Kenneth C Anderson; Steven P Treon; Guang Yang
Journal:  Blood Adv       Date:  2022-06-14

5.  Quercetin and Resveratrol Differentially Decrease Expression of the High-Affinity IgE Receptor (FcεRI) by Human and Mouse Mast Cells.

Authors:  Syed Benazir Alam; Ashley Wagner; Steven Willows; Marianna Kulka
Journal:  Molecules       Date:  2022-10-08       Impact factor: 4.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.